Erythema multiforme eruption due to SARS-COV 2: Case report.
COVID 19
Erythema multiforme
SARS-Cov 2
Targetoid eruption
Journal
Annals of medicine and surgery (2012)
ISSN: 2049-0801
Titre abrégé: Ann Med Surg (Lond)
Pays: England
ID NLM: 101616869
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
06
06
2021
revised:
20
07
2021
accepted:
25
07
2021
pubmed:
3
8
2021
medline:
3
8
2021
entrez:
2
8
2021
Statut:
ppublish
Résumé
and importance: The COVID-19 is a global pandemic that is now responsible for more than We report a new pattern with erythema multiforme (EM) lesions in a healthy patient with COVID-19 infection and no other medical background. We are facing challenging times in Dermatology. New information and cutaneous manifestations possibly related to COVID-19 are emerging every day. There are only a few case reports describing EM in patients with COVID-19. We suggest that this EM might be another pattern of exanthem associated with COVID-19 infection. Further studies are needed to evaluate whether these lesions are associated with the virus, the drug intake or any other conditions.
Identifiants
pubmed: 34336192
doi: 10.1016/j.amsu.2021.102591
pii: S2049-0801(21)00541-0
pmc: PMC8312051
doi:
Types de publication
Case Reports
Langues
eng
Pagination
102591Informations de copyright
© 2021 The Authors.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e457-e459
pubmed: 32386448
Dermatol Ther. 2020 Nov;33(6):e13899
pubmed: 32589314
Clin Exp Dermatol. 2020 Oct;45(7):892-895
pubmed: 32385858
J Clin Epidemiol. 2017 Sep;89:218-235
pubmed: 28529185
Biology (Basel). 2020 Dec 05;9(12):
pubmed: 33291502
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e373-e375
pubmed: 32386446